| CTRI Number |
CTRI/2018/07/015037 [Registered on: 24/07/2018] Trial Registered Prospectively |
| Last Modified On: |
22/01/2019 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
open label non-randomized prospective feasibility research study on human tissues |
| Study Design |
Other |
|
Public Title of Study
|
Testing of prototype radiofrequency electrode by ablation on excised, discarded cervical tissue |
|
Scientific Title of Study
|
BiRF-C Tissue Ablation Study |
| Trial Acronym |
BiTS |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vinay Rajan |
| Designation |
Clinical Research Manager |
| Affiliation |
Regional Clinical Indian Subcontinent |
| Address |
India Medtronic Pvt Ltd
Solitaire Corporate Park
Bldg No 12 4th Floor
Andheri Ghatkopar Link Road Andheri (e)
Mumbai, Maharashtra - 400093
Mumbai MAHARASHTRA 400093 India |
| Phone |
|
| Fax |
|
| Email |
vinay.rajan@medtronic.com |
|
Details of Contact Person Scientific Query
|
| Name |
Vinay Rajan |
| Designation |
Clinical Research Manager |
| Affiliation |
Regional Clinical Indian Subcontinent |
| Address |
India Medtronic Pvt Ltd
Solitaire Corporate Park
Bldg No 12 4th Floor
Andheri Ghatkopar Link Road Andheri (e)
Mumbai, Maharashtra - 400093
Mumbai MAHARASHTRA 400093 India |
| Phone |
|
| Fax |
|
| Email |
vinay.rajan@medtronic.com |
|
Details of Contact Person Public Query
|
| Name |
Vinay Rajan |
| Designation |
Clinical Research Manager |
| Affiliation |
Regional Clinical Indian Subcontinent |
| Address |
India Medtronic Pvt Ltd
Solitaire Corporate Park
Bldg No 12 4th Floor
Andheri Ghatkopar Link Road Andheri (e)
Mumbai, Maharashtra - 400093
Mumbai MAHARASHTRA 400093 India |
| Phone |
|
| Fax |
|
| Email |
vinay.rajan@medtronic.com |
|
|
Source of Monetary or Material Support
|
| India Medtronic Pvt Ltd
Solitaire Corporate Park, Building No.12,4th Floor,
Andheri -Ghatkopar Link Road, Andheri-East
Mumbai, Maharashtra 400 093
INDIA |
|
|
Primary Sponsor
|
| Name |
India Medtronic Pvt Ltd |
| Address |
Solitaire Corporate Park, Building No.12,4th Floor,
Andheri -Ghatkopar Link Road, Andheri-East
Mumbai, Maharashtra 400 093
INDIA
|
| Type of Sponsor |
Other [Medical Device Industry] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Medtronic Surgical Innovations |
5920 Longbow Drive, A05 B6-2,
Boulder, CO, 80301
USA
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Manjeet Arora |
Batra Hospital and Medcial Research Centre |
1 Tuglakabad Insitutional Area M B Road new Delhi
Clinical Research Department 1st Floor New Delhi DELHI |
911129958747
arora.manjeet@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Scientific Research & Ethical review committee BHMRC |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
BiRF-C is a product in research and development. The indication for the product when developed will be cervical dysplasia, |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Female |
| Details |
20-60 years of age
Patients undergoing total or radical hysterectomy due to non-malignant disease, during routine clinical care.
The subject or her Legally Authorized Representative (LAR) has been informed about the nature of the study and the patient informed consent for study participation has been obtained prior to performing any study-related procedures from the subject or Legally Authorized Representative, as per applicable local requirements
Study team able to test discarded excised tissues within 5 hours after hysterectomy
|
|
| ExclusionCriteria |
| Details |
Malignancy/cancerous tissue in the uterus
Not willing to consent
|
|
|
Method of Generating Random Sequence
|
|
|
Method of Concealment
|
|
|
Blinding/Masking
|
|
|
Primary Outcome
|
| Outcome |
TimePoints |
| Ablation depth |
Within five hours of hysterectomy performed as per routine clinical care |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Not applicable |
Not applicable |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
14/08/2018 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
This study is being conducted in order to gather inputs for a prototype product. Hence the data will not be published. |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Study of ablation depth using new bipolar electrode prototype design (BiRF-C) utilizing Radio Frequency technology in excised human cervix tissue, discarded during routine clinical care BiRF-C is a product in research and development. The indication for the product when developed will be cervical dysplasia. In the proposed study the device prototype will be used for testing tissue ablation depth in discarded fresh (<5 hours) cervical tissue specimen at different power settings configurations This study intends to assess the feasibility of a new technology, BiRF-C ablation prototype for cervical tissue ablation. Results will provide inputs to further modify the prototype design and identify the optimum power, ablation duration, form factor and electrical design in the future version(s) of the prototype. |